I am very happy to announce that my last postdoctoral work has been published today in Nature Partner Journal Vaccines! We describe the role of neutrophils in the generation of antigen-specific T cell responses during vaccinia virus infection. #vaccine nature.com/articles/s4154…

There are many rewards to being a scientist (discoveries, papers, trainee becomes PI, etc…), but this one is special: First patient receives a #cancer therapy developed in your lab 😁. Keeping 🤞 for #Treg reprogramming: businesswire.com/news/home/2021…

I am thrilled to read that today a patient is receiving a first dose of #cancer therapy that Mempel Lab and I discovered together a couple of years ago. #Treg reprogramming is now! businesswire.com/news/home/2021…

Glad to have been a part of the effort! Congrats Steffi!! 🐁🧫🧬nature.com/articles/s4155…

I am very excited and thankful to be part of this work published on Nature Biomedical Engineering. Good job Stefanie, Viktoria and Sebastian! CXCR6 on CD8 T cells is a key for their anti-tumor activity. nature.com/articles/s4155…

Orchestrated tumor infiltration and immunosuppressive-resistant CAR T cell therapy for solid tumors. I am very grateful to all the scientists that contributed to this work! #celltherapy 🧬🔬🐁 advances.sciencemag.org/content/7/24/e…

I am excited and thankful to be among the authors of this nice work! Great job @bcadilha, Reda and Sebastian! CCR8 and DNR into CAR T cells to be effective against solid tumors. advances.sciencemag.org/content/7/24/e…

I am excited and thankful to be among the authors of this work published on Cell! Great job Francesco Marangoni e Mempel Lab! CTLA-4-blockade triggers Treg cell hyper-proliferation which offsets the efficacy of immunecheckpoint therapy. disq.us/t/3yc49gt

Adoptive TIL therapy works in metastatic non-small cell lung cancer! Great news!!! nature.com/articles/s4159…

In the latest issue! CXCR6 plays an important role in tumor-infiltrating cytotoxic T cells to sustain T cell-mediated immune control of tumors #cancerresearch Mempel Lab MassGeneral Medicine bit.ly/3sut1a3

Online Now: An intimate encounter: DC3s empower anti-tumor CTLs dlvr.it/S6PT9K

"Don’t get me wrong. We need data produced from new technologies to advance understanding. But this is only the first step." go.nature.com/3k9EcSZ

I am excited and thankful to be among the authors of this work published on Immunity. Fantastic job from Aleksandra Ozga and Andrew Luster on showing how CXCR3-CXCL10 controls T cell heterogeneity during chronic infection. cell.com/immunity/fullt…

I am so excited and very thankful to be among the authors of this work published on nature. Great job from Georgiana and Miguel on building behavioural landscapes of different cell types by using live imaging. Kudos to Andrés Hidalgo and his team. nature.com/articles/s4158…

I am thrilled to announce that the Schenkel Lab will open it’s doors on Sept 15th MD Anderson Cancer Center MD Anderson-UTH Grad. This is the culmination of many years of blood, sweat, and tears. I am over the moon excited to join such an incredible group of people focused on #endcancer. 1/

I am thrilled to announce that the Pauken Lab will officially be opening it’s doors tomorrow Sept 15th MD Anderson Cancer Center MD Anderson-UTH Grad GSBS Immunology Program. I cannot wait to become a part of this incredible community focused on #endcancer. 1/

I am very happy to share our translational studies on Treg fragility. Mepazine works in patient-derived organotypic tumor spheroids! Great job of all team and our CEO Peter Keller! Clinical trials ongoing... Stay tuned! meridian.allenpress.com/innovationsjou…

It was a great experience and pleasure to writhe this review with The Pittet Lab Mempel Lab Christopher Garris ! DC journey just started 😀 sciencedirect.com/science/articl…